Overall, results concluded that NR2F1‐AS1 knockdown inhibited the migration, invasion and tumour growth of oxaliplatin‐resistant HCC cells in vitro and in vivo, suggesting the potential tumour‐promoting role of NR2F1‐AS1 in oxaliplatin resistance of HCC. The gene discussed is NR2F1; the disease is hepatocellular carcinoma.